APA (7th ed.) Citation

AIu, Z., EG, L., OIu, V., GA, D., TI, K., SS, L., . . . AG, T. (2007). [Prognosis factors in imatinib mesilate therapy in patients with a chronic phase of Ph-positive chronic myeloid leukemia: Data from a multicenter non-randomized trial in Russia]. Terapevticheskii arkhiv, 79(8), 17.

Chicago Style (17th ed.) Citation

AIu, Zaritskiĭ, et al. "[Prognosis Factors in Imatinib Mesilate Therapy in Patients with a Chronic Phase of Ph-positive Chronic Myeloid Leukemia: Data from a Multicenter Non-randomized Trial in Russia]." Terapevticheskii Arkhiv 79, no. 8 (2007): 17.

MLA (9th ed.) Citation

AIu, Zaritskiĭ, et al. "[Prognosis Factors in Imatinib Mesilate Therapy in Patients with a Chronic Phase of Ph-positive Chronic Myeloid Leukemia: Data from a Multicenter Non-randomized Trial in Russia]." Terapevticheskii Arkhiv, vol. 79, no. 8, 2007, p. 17.